Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Joy Kie Corp Ltd
SZSE:300994
|
CN |
|
Chongqing Fuling Zhacai Group Co Ltd
SZSE:002507
|
CN |
|
G
|
Gujarat Lease Financing Ltd
NSE:GLFL
|
IN |
|
Tsunagu Group Holdings Inc
TSE:6551
|
JP |
|
S
|
Siemens Gamesa Renewable Energy SA
XETRA:GTQ1
|
ES |
|
S
|
Shanthi Gears Ltd
NSE:SHANTIGEAR
|
IN |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (27.1), the stock would be worth kr-0.35 (519% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -6.5 | kr0.08 |
0%
|
| Industry Average | 27.1 | kr-0.35 |
-519%
|
| Country Average | 10.3 | kr-0.13 |
-259%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
kr111.7m
|
/ |
Jan 2026
kr-16.9m
|
= |
|
|
kr111.7m
|
/ |
Dec 2026
kr2m
|
= |
|
|
kr111.7m
|
/ |
Dec 2027
kr-23m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| DK |
|
Pharma Equity Group A/S
CSE:PEG
|
101.6m DKK | -6.5 | -4 | |
| DE |
|
Vonovia SE
XETRA:VNA
|
20.4B EUR | 21.5 | 5.5 | |
| HK |
S
|
Swire Properties Ltd
HKEX:1972
|
143.2B HKD | 20.7 | -93.4 | |
| IL |
|
Azrieli Group Ltd
TASE:AZRG
|
54.1B ILS | 35.3 | 28.6 | |
| BM |
|
Hongkong Land Holdings Ltd
SGX:H78
|
17.6B USD | -83.1 | 13.9 | |
| CH |
|
Swiss Prime Site AG
SIX:SPSN
|
11B CHF | 38.6 | 29 | |
| CN |
|
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
|
110.1B HKD | 17.5 | 24.1 | |
| SG |
|
Capitaland Investment Ltd
SGX:9CI
|
14.4B SGD | 28.4 | 97.7 | |
| CL |
P
|
Plaza SA
SGO:MALLPLAZA
|
9.7T CLP | 20.8 | 6.8 | |
| CN |
|
Zhejiang China Commodities City Group Co Ltd
SSE:600415
|
67.6B CNY | 13 | 16.1 | |
| PH |
S
|
SM Prime Holdings Inc
XPHS:SMPH
|
582.7B PHP | 9.8 | 11.9 |
Market Distribution
| Min | 0.6 |
| 30th Percentile | 5.1 |
| Median | 10.3 |
| 70th Percentile | 16.4 |
| Max | 10 882.4 |
Other Multiples
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
